You are subscribed!

Home

Blog

Methodology

About

Contact

Multi-Condition QSAR Model for the Virtual Design of Chemicals with Dual Pan-Antiviral and Anti-Cytokine Storm Profiles

This work reported for the first time, multi-condition model based on quantitative structure–activity relationships and an artificial neural network (mtc-QSAR-ANN) for the virtual design of new drug-like molecules with potential pan-antiviral activity (against SARS-Cov-1, SARS, Cov-2, influenza A and B viruses, and RSV) while also exhibiting anti-cytokine storm profiles (against caspase-1 and TNF-alpha).

PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors

Here, we reported for the first time two models that combined perturbation theory with machine learning via a multilayer perceptron network (PTML-MLP) to perform the virtual design and prediction of molecules with acceptable drug-likeness that can simultaneously inhibit multiple pancreatic cancer (PANC) cell lines as well as the PANC-related proteins named caspase-1, TNF-alpha, and the insulin-like growth factor 1 receptor (IGF1R).

QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites

In this study, we reported the first multi-target model based on quantitative structure-activity relationships and a multilayer perceptron neural network (mt-QSAR-MLP) to virtually design and predict versatile drug-like inhibitors of proteins involved in the survival and/or infectivity of four different pathogenic parasites, namely Trypanosoma cruzi, Trypanosoma brucei brucei, Plasmodium falciparum, and Toxoplasma gondii. Docking calculations converged with the mt-QSAR-MLP model regarding the multi-target profile of the designed molecules.

SOFTWARE & DATABASES

This includes a list of software and databases used in my works as well as others of great importance in the context of computer-aided molecular design, chemoinformatics, and related scientific disciplines.

ANTIVIRALS

Virtual design of new molecules with potential pan-antiviral activity.

CANCERS

In Silico generation of multi-protein and/or multi-cell inhibitors against several cancers.

ANTIPARASITICS

Computer-aided discovery of multi-target inhibitors of proteins in diverse parasites.

PESTICIDES

Computational design of virtually potent fungicides and insecticides.

PEPTIDE DISCOVERY

Rational in silico design of bioactive and toxicologically safe peptides.

OTHERS

Use of the methodology named Perturbation Theory & Machine Learning (PTML) for virtual screening.